PrimeraDx, Quest Co-developing MDx to Support Drug Development | GenomeWeb

NEW YORK (GenomeWeb News) – PrimeraDx today announced a deal with Quest Diagnostics to co-develop molecular diagnostic products and services.

The focus of the non-exclusive deal is to support drug developers in the clinical development of targeted therapeutics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.